Dubai (19 April 2012): Patients with rheumatic heart disease (RHD) are being admitted to hospital too late to prevent the need for heart surgery, according to a new study carried out by doctors in Yemen and presented today at the World Congress of Cardiology.
RHD is a devastating consequence of repeated episodes of rheumatic fever. The disease progresses over time and if it is not caught in the early stages, patients develop heart valve damage and will ultimately need surgery to replace the damaged valve(s).
A recent study in Yemen showed that 43 per cent (n=89/206) of patients admitted to hospital with RHD had rheumatic mitral stenosis – a narrowing of the opening of the heart's mitral value – and more than half were considered to have severe stenosis. Of those 87 patients followed, 53 per cent were recommended for percutaneous balloon mitral valvuloplasty (BMVP) – where the abnormally thickened mitral valve is dilated; a further 29 per cent were recommended for valve replacement surgery; while only 18 per cent were entered into a follow-up programme without interventional therapy of any kind.
"These results clearly demonstrate that RHD patients are seeking treatment from their doctors in the very late stages of their disease," said Dr. A. Sharafaddeen, Algomori Hospital, Taiz, Yemen. "But the management of these patients is costly. This money could be rather used much more efficiently in preventing and screening for the disease in its early stages."
Indeed, coordinated screening and control programmes to prevent progression to severe RHD can be carried out relatively cheaply.
"RHD can be prevented easily using penicillin – a cheap and readily available treatment," said Dr. Fahad Baslaib, President, Emirates Cardiac Society. "The funding required is minimal and control could be achieved by re-prioritizing existing budgets. We therefore have to consider implementing screening programmes in this region as a matter of urgency."
RHD is a substantial global health problem that can result in irreversible heart damage and death. It occurs predominately in developing countries and is also common in poorer populations in middle-income countries (e.g. Brazil, India) and some indigenous populations in wealthy countries (Australia, New Zealand). RHD will continue to be a global problem unless current prevention initiatives are expanded and sustained.
Previous estimates state that more than 15 million people have RHD and that 350,000 people die each year while many more are left disabled.About the World Congress of Cardiology
Charanjit Jagait | EurekAlert!
Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University
Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University
Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.
Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...
Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.
Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
09.11.2018 | Event News
06.11.2018 | Event News
23.10.2018 | Event News
16.11.2018 | Health and Medicine
16.11.2018 | Life Sciences
16.11.2018 | Life Sciences